Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tecomella undulata is a medicinal plant belonging to the family Bignoniaceae, widely used in traditional Ayurvedic medicine. The heartwood, stem bark, leaves, and seeds are utilized for their therapeutic properties[4]. The plant contains a variety of phytochemicals including flavonoids (such as quercetin and kaempferol), sterols (stigmasterol and β-sitosterol), thiazoline derivatives, phytol, phthalic acid derivatives, and others[3][5]. Tecomella undulata exhibits diverse pharmacological activities such as antibacterial, antifungal, anticancer effects; it has been traditionally used for ailments like syphilis, leukoderma (vitiligo), blood disorders, swelling/inflammation, leucorrhoea (vaginal discharge), enlargement of spleen and other conditions[1][5]. Its mechanism of action is attributed to its rich content of bioactive compounds with antimicrobial and anti-inflammatory properties; however specific molecular targets have not been fully elucidated in modern pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tecomella undulata.